SciELO - Scientific Electronic Library Online

 
vol.23 issue4Nutritional therapy and neonatal sepsisMeningitis and infective endocarditis caused by Rhodotorula mucilaginosa in an immunocompetent patient author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Revista Brasileira de Terapia Intensiva

Print version ISSN 0103-507X

Abstract

RABELLO, Lígia Sarmet Cunha Farah et al. Novel biomarkers in severe community-acquired pneumonia. Rev. bras. ter. intensiva [online]. 2011, vol.23, n.4, pp. 499-506. ISSN 0103-507X.  http://dx.doi.org/10.1590/S0103-507X2011000400016.

Community-acquired pneumonia (CAP) is the most common infectious disease requiring admission to intensive care units (ICUs), and achieving an early and precise diagnosis of CAP remains a challenge. Biomarkers play an important role in improving clinical judgment in the emergency room and are adjuvant in evaluating treatment responses. Novel biomarkers, such as cortisol, pro-adrenomedullin and endothelin-1, have been shown to be associated with disease severity and short-term outcomes. This review article focuses on the clinical use of novel biomarkers, severity prediction and treatment monitoring as well as future directions of the field.

Keywords : Biological makers; Pneumonia; drug therapy; Community-acquired infections; drug therapy; Community-acquired infections; prevention & control.

        · abstract in Portuguese     · text in English | Portuguese     · pdf in English | Portuguese